Revelation Biosciences, Inc. Unit
REVBU
REVBU was delisted on the 11th of January, 2023.
1 hedge funds and large institutions have $58K invested in Revelation Biosciences, Inc. Unit in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
14% more capital invested
Capital invested by funds: $51K → $58K (+$7K)
67% less funds holding
Funds holding: 3 → 1 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CFN
1
Cordasco Financial Network
Naples,
Florida
| $58K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$2K | -167 | Closed |
|
REVBU Hedge Fund Activity: Q4 2021 in Review
1 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q4 2021, worth a combined $58K — up 14% from $51K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of REVBU and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $2K sold.
- 1 institutional investor held Revelation Biosciences, Inc. Unit (REVBU) as of Q4 2021, down from 3 in Q3 2021.
- Funds reported $58K of Revelation Biosciences, Inc. Unit stock for Q4 2021, up 14% quarter-over-quarter.
- 0 funds opened new Revelation Biosciences, Inc. Unit positions in Q4 2021 and 2 closed out, a net change of -2 holders.
- The largest Revelation Biosciences, Inc. Unit seller in Q4 2021 was UBS Group, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2021.